News | Radiation Dose Management | October 01, 2015

Real-Time Dose Monitoring to Improve Staff Safety

raysafe, i2, staff dose monitoring

October 1, 2015 — The first and only system that delivers real-time X-ray radiation dose monitoring for physicians and clinicians will be featured at Radiological Society of North America (RSNA) 2015 annual meeting. The RaySafe i2 is an active dosimetry system that enables effective behavior change by showing physicians and staff their real-time dose during live procedures. Interventional radiologists, interventional cardiologists and electrophysiologists and their teams can all see their personal radiation exposure and adjust position or make other live changes to lower their exposure to ionizing radiation.

Just like a stop light, a visual display shows colored indications (red, yellow, green) to give each individual user insight about the current dose exposure and the possibility to act accordingly. The accumulated dose per individual user is also captured and can be accessed on the touch screen display.  In addition to the live data, a dose dashboard in the Dose Manager software captures total dose history and easily generate reports for staff use and archives. Interventional radiology and cardiology departments, along with hospital administration can better manage staff dose and help keep staff safe.

Physician feedback has indicated that because dose is invisible, the RaySafe i2, with its clear, real-time indicators, is a proven way to reduce dose. This is a paradigm shifting, behavior changing technology.

RaySafe i2 dosimeters are designed for interventionalists and their staffs who are exposed to radiation. The new technology displays radiation exposure levels in real-time, creating awareness of exposure levels so immediate steps can be taken to minimize radiation, while continuing to deliver a high standard of care to patients.

For more information: www.raysafe.com, www.lowermydose.com  

 

 

Related Content

Corindus Announces First Patient Enrolled in PRECISION GRX Registry
News | Robotic Systems| September 18, 2017
September 18, 2017 — Corindus Vascular Robotics Inc.
Two-Year ILLUMENATE Trial Data Demonstrate Efficacy of Stellarex Drug-Coated Balloon
News | Drug-Eluting Balloons| September 18, 2017
Philips announced the two-year results from the ILLUMENATE European randomized clinical trial (EU RCT) demonstrating...
Sentinel Cerebral Protection System Significantly Reduces Stroke and Mortality in TAVR
News | Embolic Protection Devices| September 18, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the...
Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Feature | Cath Lab| September 14, 2017
September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials
Mississippi Surgical and Vascular Center Uses Toshiba Ultimax-i FPD to Save Patients' Limbs
News | Angiography| September 14, 2017
The southern U.S. sees some of the highest numbers of chronic medical conditions, such as peripheral artery disease...
Sponsored Content | Videos | Structural Heart Occluders| September 13, 2017
Ziyad Hijazi, M.D., MPH, MSCAI, FACC, director of the cardiac program and chair of the Department of Pediatrics at Si
Philips Showcases Integrated Vascular Solutions at VIVA 2017
News | Peripheral Artery Disease (PAD)| September 13, 2017
Philips announced its presence at the Vascular Interventional Advances (VIVA 17) Annual Conference in Las Vegas from...
Medtronic Announces Japanese Regulatory Approval for In.Pact Admiral Drug-Coated Balloon
News | Drug-Eluting Balloons| September 13, 2017
Medtronic plc announced that the In.Pact Admiral Drug-Coated Balloon (DCB) received approval from the Japanese Ministry...
PQ Bypass Reports Positive Results for Detour System in Patients With Long Femoropopliteal Blockages
News | Peripheral Artery Disease (PAD)| September 13, 2017
A subset analysis of the DETOUR I clinical trial showed promising safety and effectiveness results of PQ Bypass’ Detour...
Overlay Init